在多中心肿瘤临床试验中使用PET进行疗效监测:面临的挑战
PET分子成像已成为肿瘤患者临床诊疗的重要工具,将PET整合进多中心试验可提供有价值的科学见解并塑造未来临床实践,但面临放射性药物可及性与监管合规、扫描时间、成像与重建方案标准化、质量控制、图像处理与分析等一系列后勤与方法学挑战。
要点
- PET整合进多中心试验面临放射性药物可及性与监管合规、研究用扫描时间等后勤挑战
- 成像与重建方案标准化、质量控制、图像处理与分析至关重要
- 图像与定量结果协调策略可在多中心认证项目框架内实施
核心结论
- 将PET纳入多中心试验是保证PET在常规临床诊疗中进一步发展的必要条件,并可能产生非常有价值的科学见解。
研究设计与样本
- 本文为综述,围绕在多中心肿瘤临床试验中使用PET进行疗效监测所面临的后勤与方法学挑战进行讨论。
主要发现
- 挑战涵盖PET放射性药物的可及性与监管合规,以及研究目的所需扫描时间的可及性。
- 成像与重建方案标准化、质量控制、图像处理与分析至关重要。
- 图像与定量结果协调策略可在多中心认证项目框架内实施。
- 数据分析可在本地或通过集中审阅进行;疗效评估可目视或采用更定量方法,取决于研究问题;基于网络的方案可实现大规模实时集中审阅。
- 未来具体挑战包括将PET/MRI扫描仪纳入多中心试验以及整合影像组学分析。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Molecular imaging with PET has emerged as a powerful imaging tool in the clinical care of oncological patients. Assessing therapy response is a prime application of PET and so the integration of PET into multicentre trials can offer valuable scientific insights and shape future clinical practice. However, there are a number of logistic and methodological challenges that have to be dealt with. These range from availability and regulatory compliance of the PET radiopharmaceutical to availability of scan time for research purposes. Standardization of imaging and reconstruction protocols, quality control, image processing and analysis are of paramount importance. Strategies for harmonization of the final image and the quantification result are available and can be implemented within the scope of multicentre accreditation programmes. Data analysis can be performed either locally or by centralized review. Response assessment can be done visually or using more quantitative approaches, depending on the research question. Large-scale real-time centralized review can be achieved using web-based solutions. Specific challenges for the future are inclusion of PET/MRI scanners in multicentre trials and the incorporation of radiomic analyses. Inclusion of PET in multicentre trials is a necessity to guarantee the further development of PET for routine clinical care and may yield very valuable scientific insights.
引用
- Deroose CM, Stroobants S, Liu Y, et al. Using PET for therapy monitoring in oncological clinical trials: challenges ahead. Eur J Nucl Med Mol Imaging. 2017. PMID: 28451825. doi:10.1007/s00259-017-3689-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。